TY - JOUR
T1 - Author Correction
T2 - Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial (Nature Medicine, (2022), 28, 12, (2504-2511), 10.1038/s41591-022-02102-9)
AU - Vardeny, Orly
AU - Fang, James C.
AU - Desai, Akshay S.
AU - Jhund, Pardeep S.
AU - Claggett, Brian
AU - Vaduganathan, Muthiah
AU - de Boer, Rudolf A.
AU - Hernandez, Adrian F.
AU - Lam, Carolyn S.P.
AU - Inzucchi, Silvio E.
AU - Martinez, Felipe A.
AU - Kosiborod, Mikhail N.
AU - DeMets, David
AU - O’Meara, Eileen
AU - Zieroth, Shelley
AU - Comin-Colet, Josep
AU - Drozdz, Jaroslaw
AU - Chiang, Chern En
AU - Kitakaze, Masafumi
AU - Petersson, Magnus
AU - Lindholm, Daniel
AU - Langkilde, Anna Maria
AU - McMurray, John J.V.
AU - Solomon, Scott D.
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Correction to: Nature Medicine. Published online 15 December 2022. In the version of this article initially published, there was an error in the abstract, where in the sentence now reading, in part, “In participants with HFimpEF… first worsening heart failure events (HR = 0.84),” the hazard ratio originally read “0.78,” while in the second paragraph of the “Outcomes by HFimpEF status” Results subsection, in the sentence now reading, in part, “The effect of dapagliflozin on HF outcomes was also similar in those with HFimpEF (HR = 0.84, 95% CI = 0.61–1.14) and those with LVEF consistently over 40% (HR = 0.78),” the hazard ratio values were mistakenly interchanged. The values have been updated in the HTML and PDF versions of the article.
AB - Correction to: Nature Medicine. Published online 15 December 2022. In the version of this article initially published, there was an error in the abstract, where in the sentence now reading, in part, “In participants with HFimpEF… first worsening heart failure events (HR = 0.84),” the hazard ratio originally read “0.78,” while in the second paragraph of the “Outcomes by HFimpEF status” Results subsection, in the sentence now reading, in part, “The effect of dapagliflozin on HF outcomes was also similar in those with HFimpEF (HR = 0.84, 95% CI = 0.61–1.14) and those with LVEF consistently over 40% (HR = 0.78),” the hazard ratio values were mistakenly interchanged. The values have been updated in the HTML and PDF versions of the article.
UR - http://www.scopus.com/inward/record.url?scp=85150020835&partnerID=8YFLogxK
U2 - 10.1038/s41591-023-02302-x
DO - 10.1038/s41591-023-02302-x
M3 - Comment/Letter to the editor
C2 - 36932245
AN - SCOPUS:85150020835
SN - 1078-8956
VL - 29
SP - 3269
JO - Nature Medicine
JF - Nature Medicine
IS - 12
ER -